* Mediscience Technology has partnered with equity investor Infotonics Technology Center (a consortium of Corning, Eastman Kodak and Xerox, 18 New York State Universities, State and Federal Government Agencies). Both companies have committed to developing a product --- the “Compact Photonic Explorer” (CPE), which is a diagnostic pill for medical applications. The product in development has a photonic sensor that uses ultraviolet (UV) light to remotely monitor the health of human tissue in various environments using Mediscience IP. The product is being designed to take a biopsy of various areas in the human digestive tract through spectroscopy. The company’s first development project for the CPE is to target diagnosing various forms of cancer throughout the GI tract.

* (see CITIGROUP/Smith Barney Analyst Report 10-1-2004 by Peter Bye. Page 20 (Mediscience/Infotonics)

Ingestible Pill Camera with fluorescence Spectroscopy IP

Market Size

• Over 95 million Americans experience some form of digestive problem.
• Over 10 million people are hospitalized each year for GI problems.
• Total health care costs exceed $40 billion annually.
• Gastrointestinal office visits exceed 45 million annually.
• Molecular diagnostic IP capability a major advance compared to competitor Given Imaging

– New England Journal of Medicine July 29, 2004 – Capsule Endsscopy Technology

Features and Benefits

• Patented technology – fluorescence and optical spectroscopy with 25 Mediscience patents surrounding the CPE.
• CPE has enhanced capability through optical biopsy IP; thereby increasing the facility for detecting abnormal areas.
• Direct path to diagnosis – CPE’s use of fluorescence and optical spectroscopy allows for the physician to identify cancer and disease of the auto digestive tract, in realtime.
• High quality color images
• Non-invasive, patient-friendly procedure that is easily ingested and does not require sedation
• Convenient digital reporting, storage and retrieval capabilities

• Cost-effective diagnostic tool for health care providers it can help to avoid unnecessary and painful diagnostic tests based on a higher expected diagnostic yield and can be performed in an outpatient setting

View research paper commissioned by Infotonics and written by the New York State Science and Technology Law Center at Syracuse University College of Law dated March 31, 2006.